Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04587869 · ClinicalTrials.gov registry record · NA
Still Climbin': An Intervention to Improve Coping Among Black Sexual Minority Men
A NA study, sponsored by RAND.
- Terminated
- Registry status
- NA
- Development phase
- 369
- Enrollment target
NCT04587869: Clinical Trial NA study, sponsored by RAND.
NCT04587869 is a NA study that was terminated before completion, run by RAND. The registered enrollment target is 369 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04587869, a NA study, was terminated before completion, sponsored by RAND.
- TERMINATED
- Registry status
- NA
- Development phase
- 369 participants
- Enrollment target
Study Summary
This study consists of a randomized controlled trial of a multi-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Primary intervention objectives include increasing health care engagement and receipt of evidence-based preventive care, as well as better coping and reduced anticipated and internalized stigma, and medical mistrust among intervention participants.
Primary Outcome
Indicator that the individual reported (1) fewer than 1 ambulatory visit AND (2) at least 1 emergency department visit (without subsequent hospitalization) or at least 1 hospitalization in the past 4 months at any of the 3 follow-up assessments (4, 8, and 12 months post-baseline)
Interventions
- BEHAVIORAL CBT Coping Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2025-03-20 |
| Phase | NA |
Why NCT04587869 stopped before completion
NCT04587869 is an interventional study that assigns participants to a tested intervention. The registered 369 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which CBT Coping Intervention is the first listed.
NCT04587869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04587869 about?
NCT04587869 is a clinical study titled "Still Climbin': An Intervention to Improve Coping Among Black Sexual Minority Men". This study consists of a randomized controlled trial of a multi-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Primary intervention objectives include increasing health care engagement ...
What is the current status of trial NCT04587869?
This trial is currently terminated. It is a NA study. The enrollment target is 369 participants. The study started on 2021-02-09. Estimated completion is 2025-03-20.
What interventions are being tested in trial NCT04587869?
The interventions under investigation include: CBT Coping Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04587869?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04587869's enrollment target sits among peer trials
369 281st of 2000 higher than 1,718 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06114836 · 369 participants · NA
GERD Infant Feeding Therapeutics Trial (GIFT Trial)
- NCT06585410 · 369 participants · Phase 3
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- NCT07256717 · 369 participants · NA
BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI